Cargando…

Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia

Parkinson disease (PD) is a progressive, neurodegenerative disorder affecting over 6.1 million people worldwide. Although the cause of PD remains unclear, studies of highly penetrant mutations identified in early-onset familial parkinsonism have contributed to our understanding of the molecular mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, Jenny I, Cheng, Mary Hongying, Font, Josep, Schwartz, Alexandra C, Ledwitch, Kaitlyn, Duran, Amanda, Mabry, Samuel J, Belovich, Andrea N, Zhu, Yanqi, Carter, Angela M, Shi, Lei, Kurian, Manju A, Fenollar-Ferrer, Cristina, Meiler, Jens, Ryan, Renae Monique, Mchaourab, Hassane S, Bahar, Ivet, Matthies, Heinrich JG, Galli, Aurelio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131106/
https://www.ncbi.nlm.nih.gov/pubmed/34002696
http://dx.doi.org/10.7554/eLife.68039
_version_ 1783694649295110144
author Aguilar, Jenny I
Cheng, Mary Hongying
Font, Josep
Schwartz, Alexandra C
Ledwitch, Kaitlyn
Duran, Amanda
Mabry, Samuel J
Belovich, Andrea N
Zhu, Yanqi
Carter, Angela M
Shi, Lei
Kurian, Manju A
Fenollar-Ferrer, Cristina
Meiler, Jens
Ryan, Renae Monique
Mchaourab, Hassane S
Bahar, Ivet
Matthies, Heinrich JG
Galli, Aurelio
author_facet Aguilar, Jenny I
Cheng, Mary Hongying
Font, Josep
Schwartz, Alexandra C
Ledwitch, Kaitlyn
Duran, Amanda
Mabry, Samuel J
Belovich, Andrea N
Zhu, Yanqi
Carter, Angela M
Shi, Lei
Kurian, Manju A
Fenollar-Ferrer, Cristina
Meiler, Jens
Ryan, Renae Monique
Mchaourab, Hassane S
Bahar, Ivet
Matthies, Heinrich JG
Galli, Aurelio
author_sort Aguilar, Jenny I
collection PubMed
description Parkinson disease (PD) is a progressive, neurodegenerative disorder affecting over 6.1 million people worldwide. Although the cause of PD remains unclear, studies of highly penetrant mutations identified in early-onset familial parkinsonism have contributed to our understanding of the molecular mechanisms underlying disease pathology. Dopamine (DA) transporter (DAT) deficiency syndrome (DTDS) is a distinct type of infantile parkinsonism-dystonia that shares key clinical features with PD, including motor deficits (progressive bradykinesia, tremor, hypomimia) and altered DA neurotransmission. Here, we define structural, functional, and behavioral consequences of a Cys substitution at R445 in human DAT (hDAT R445C), identified in a patient with DTDS. We found that this R445 substitution disrupts a phylogenetically conserved intracellular (IC) network of interactions that compromise the hDAT IC gate. This is demonstrated by both Rosetta molecular modeling and fine-grained simulations using hDAT R445C, as well as EPR analysis and X-ray crystallography of the bacterial homolog leucine transporter. Notably, the disruption of this IC network of interactions supported a channel-like intermediate of hDAT and compromised hDAT function. We demonstrate that Drosophila melanogaster expressing hDAT R445C show impaired hDAT activity, which is associated with DA dysfunction in isolated brains and with abnormal behaviors monitored at high-speed time resolution. We show that hDAT R445C Drosophila exhibit motor deficits, lack of motor coordination (i.e. flight coordination) and phenotypic heterogeneity in these behaviors that is typically associated with DTDS and PD. These behaviors are linked with altered dopaminergic signaling stemming from loss of DA neurons and decreased DA availability. We rescued flight coordination with chloroquine, a lysosomal inhibitor that enhanced DAT expression in a heterologous expression system. Together, these studies shed some light on how a DTDS-linked DAT mutation underlies DA dysfunction and, possibly, clinical phenotypes shared by DTDS and PD.
format Online
Article
Text
id pubmed-8131106
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-81311062021-05-19 Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia Aguilar, Jenny I Cheng, Mary Hongying Font, Josep Schwartz, Alexandra C Ledwitch, Kaitlyn Duran, Amanda Mabry, Samuel J Belovich, Andrea N Zhu, Yanqi Carter, Angela M Shi, Lei Kurian, Manju A Fenollar-Ferrer, Cristina Meiler, Jens Ryan, Renae Monique Mchaourab, Hassane S Bahar, Ivet Matthies, Heinrich JG Galli, Aurelio eLife Neuroscience Parkinson disease (PD) is a progressive, neurodegenerative disorder affecting over 6.1 million people worldwide. Although the cause of PD remains unclear, studies of highly penetrant mutations identified in early-onset familial parkinsonism have contributed to our understanding of the molecular mechanisms underlying disease pathology. Dopamine (DA) transporter (DAT) deficiency syndrome (DTDS) is a distinct type of infantile parkinsonism-dystonia that shares key clinical features with PD, including motor deficits (progressive bradykinesia, tremor, hypomimia) and altered DA neurotransmission. Here, we define structural, functional, and behavioral consequences of a Cys substitution at R445 in human DAT (hDAT R445C), identified in a patient with DTDS. We found that this R445 substitution disrupts a phylogenetically conserved intracellular (IC) network of interactions that compromise the hDAT IC gate. This is demonstrated by both Rosetta molecular modeling and fine-grained simulations using hDAT R445C, as well as EPR analysis and X-ray crystallography of the bacterial homolog leucine transporter. Notably, the disruption of this IC network of interactions supported a channel-like intermediate of hDAT and compromised hDAT function. We demonstrate that Drosophila melanogaster expressing hDAT R445C show impaired hDAT activity, which is associated with DA dysfunction in isolated brains and with abnormal behaviors monitored at high-speed time resolution. We show that hDAT R445C Drosophila exhibit motor deficits, lack of motor coordination (i.e. flight coordination) and phenotypic heterogeneity in these behaviors that is typically associated with DTDS and PD. These behaviors are linked with altered dopaminergic signaling stemming from loss of DA neurons and decreased DA availability. We rescued flight coordination with chloroquine, a lysosomal inhibitor that enhanced DAT expression in a heterologous expression system. Together, these studies shed some light on how a DTDS-linked DAT mutation underlies DA dysfunction and, possibly, clinical phenotypes shared by DTDS and PD. eLife Sciences Publications, Ltd 2021-05-18 /pmc/articles/PMC8131106/ /pubmed/34002696 http://dx.doi.org/10.7554/eLife.68039 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (https://creativecommons.org/publicdomain/zero/1.0/) .
spellingShingle Neuroscience
Aguilar, Jenny I
Cheng, Mary Hongying
Font, Josep
Schwartz, Alexandra C
Ledwitch, Kaitlyn
Duran, Amanda
Mabry, Samuel J
Belovich, Andrea N
Zhu, Yanqi
Carter, Angela M
Shi, Lei
Kurian, Manju A
Fenollar-Ferrer, Cristina
Meiler, Jens
Ryan, Renae Monique
Mchaourab, Hassane S
Bahar, Ivet
Matthies, Heinrich JG
Galli, Aurelio
Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
title Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
title_full Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
title_fullStr Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
title_full_unstemmed Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
title_short Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia
title_sort psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile parkinsonism-dystonia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131106/
https://www.ncbi.nlm.nih.gov/pubmed/34002696
http://dx.doi.org/10.7554/eLife.68039
work_keys_str_mv AT aguilarjennyi psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT chengmaryhongying psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT fontjosep psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT schwartzalexandrac psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT ledwitchkaitlyn psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT duranamanda psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT mabrysamuelj psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT belovichandrean psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT zhuyanqi psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT carterangelam psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT shilei psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT kurianmanjua psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT fenollarferrercristina psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT meilerjens psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT ryanrenaemonique psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT mchaourabhassanes psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT baharivet psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT matthiesheinrichjg psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia
AT galliaurelio psychomotorimpairmentsandtherapeuticimplicationsrevealedbyamutationassociatedwithinfantileparkinsonismdystonia